Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Amphastar Pharmaceuticals stock have an average target of 38, with a low estimate of 30 and a high estimate of 55. The average target predicts an increase of 56.12% from the current stock price of 24.34.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$30	$38	$35	$55
Change	+23.25%	+56.12%	+43.80%	+125.97%

Analyst Ratings

The average analyst rating for Amphastar Pharmaceuticals stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	0	0	0	0	0	0
Buy	3	3	2	1	1	2
Hold	1	1	2	2	2	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	3	3	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ekaterina Knyazkova JP Morgan	JP Morgan	Buy → Hold Downgrades $45 → $30	Buy → Hold	Downgrades	$45 → $30	+23.25%	May 12, 2025
Cerena Chen Wells Fargo	Wells Fargo	Buy Maintains $40 → $35	Buy	Maintains	$40 → $35	+43.80%	May 8, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 10, 2025
David Amsellem Piper Sandler	Piper Sandler	Hold Maintains $36 → $32	Hold	Maintains	$36 → $32	+31.47%	Mar 21, 2025
David Amsellem Piper Sandler	Piper Sandler	Buy → Hold Downgrades $66 → $36	Buy → Hold	Downgrades	$66 → $36	+47.90%	Feb 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

742.77M

Increased by 1.48%

from 731.97M

Revenue Next Year

787.12M

Increased by 5.97%

from 742.77M

EPS This Year

3.20

Increased by 4.44%

from 3.06

EPS Next Year

3.77

Increased by 18.09%

from 3.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	349.85M	437.77M	498.99M	644.40M	731.97M	742.77M	787.12M	816.67M
Revenue Growth	8.53%	25.13%	13.98%	29.14%	13.59%	1.48%	5.97%	3.75%
EPS	0.03	1.25	1.74	2.60	3.06	3.20	3.77	3.93
EPS Growth	-96.96%	4,090.97%	39.20%	49.43%	17.69%	4.44%	18.09%	4.22%
Forward PE	-	-	-	-	-	7.62	6.45	6.19
No. Analysts	-	-	-	-	-	8	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	777.4M	843.2M	882.3M
Avg	742.8M	787.1M	816.7M
Low	699.7M	732.1M	759.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	6.2%	13.5%	12.1%
Avg	1.5%	6.0%	3.8%
Low	-4.4%	-1.4%	-3.5%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	3.68	4.21	4.29
Avg	3.20	3.77	3.93
Low	2.88	3.39	3.57

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	20.1%	31.7%	13.8%
Avg	4.4%	18.1%	4.2%
Low	-5.8%	6.1%	-5.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.